196 related articles for article (PubMed ID: 3938090)
21. A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.
Kansiime F; Adibaku S; Wamboga C; Idi F; Kato CD; Yamuah L; Vaillant M; Kioy D; Olliaro P; Matovu E
Parasit Vectors; 2018 Feb; 11(1):105. PubMed ID: 29471865
[TBL] [Abstract][Full Text] [Related]
22. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
[TBL] [Abstract][Full Text] [Related]
23. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
24. Role of antibody in the elimination of trypanosomes after DL-alpha-difluoromethylornithine chemotherapy.
de Gee AL; McCann PP; Mansfield JM
J Parasitol; 1983 Oct; 69(5):818-22. PubMed ID: 6423794
[TBL] [Abstract][Full Text] [Related]
25. Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis.
Bitonti AJ; Bacchi CJ; McCann PP; Sjoerdsma A
Biochem Pharmacol; 1985 May; 34(10):1773-7. PubMed ID: 3924048
[TBL] [Abstract][Full Text] [Related]
26. Advances in sleeping sickness therapy.
Van Nieuwenhove S
Ann Soc Belg Med Trop; 1992; 72 Suppl 1():39-51. PubMed ID: 1417168
[TBL] [Abstract][Full Text] [Related]
27. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)].
Hamon JF; Camara P
Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798
[TBL] [Abstract][Full Text] [Related]
28. [A new molecule in antiparasitic therapy: alpha-difluoromethylornithine].
Furet Y; Duong TH; Combescot C; Breteau M
Pathol Biol (Paris); 1987 Apr; 35(4):398-404. PubMed ID: 3108836
[TBL] [Abstract][Full Text] [Related]
29. Curative effect of alpha-difluoromethylornithine on fatal Trypanosoma congolense infection in mice.
Karbe E; Böttger M; McCann PP; Sjoerdsma A; Freitas EK
Tropenmed Parasitol; 1982 Sep; 33(3):161-2. PubMed ID: 6814025
[TBL] [Abstract][Full Text] [Related]
30. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense].
Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ
Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607
[TBL] [Abstract][Full Text] [Related]
31. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
[TBL] [Abstract][Full Text] [Related]
32. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients.
Taelman H; Schechter PJ; Marcelis L; Sonnet J; Kazyumba G; Dasnoy J; Haegele KD; Sjoerdsma A; Wery M
Am J Med; 1987 Mar; 82(3 Spec No):607-14. PubMed ID: 3103442
[TBL] [Abstract][Full Text] [Related]
33. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.
Khonde N; Pépin J; Mpia B
Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773
[TBL] [Abstract][Full Text] [Related]
34. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.
Bacchi CJ; Brun R; Croft SL; Alicea K; Bühler Y
Antimicrob Agents Chemother; 1996 Jun; 40(6):1448-53. PubMed ID: 8726018
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
[TBL] [Abstract][Full Text] [Related]
36. Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.
Priotto G; Pinoges L; Fursa IB; Burke B; Nicolay N; Grillet G; Hewison C; Balasegaram M
BMJ; 2008 Mar; 336(7646):705-8. PubMed ID: 18321960
[TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Sjoerdsma A; Saric M; Clarkson AB
Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
[TBL] [Abstract][Full Text] [Related]
38. Antagonism by polyamines of the curative effects of alpha-difluoromethylornithine in Trypanosoma brucei brucei infections.
Nathan HC; Bacchi CJ; Hutner SH; Rescigno D; McCann PP; Sjoerdsma A
Biochem Pharmacol; 1981 Nov; 30(21):3010-3. PubMed ID: 6797437
[No Abstract] [Full Text] [Related]
39. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
Zweygarth E; Kaminsky R
Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
